Unique ID issued by UMIN | UMIN000032175 |
---|---|
Receipt number | R000036686 |
Scientific Title | Prophylaxis of post-bronchoscopy pneumonia with antibiotics based on a risk prediction score |
Date of disclosure of the study information | 2018/04/17 |
Last modified on | 2020/10/11 21:09:23 |
Prophylaxis of post-bronchoscopy pneumonia with antibiotics based on a risk prediction score
PPAP study
Prophylaxis of post-bronchoscopy pneumonia with antibiotics based on a risk prediction score
PPAP study
Japan |
pneumonia
Pneumology |
Others
NO
To examine the prevalence of post-bronchoscopy pneumonia in high-risk cases treated with prophylactic antibiotics
Safety,Efficacy
Exploratory
Not applicable
Prevalence of post-bronchoscopy pneumonia in the cases treated with prophylactic antibiotics
1. Proportion of unexpected changes in the treatment of lung cancer within 30 days after bronchoscopy in the cases treated with prophylactic antibiotics
2. Prevalence of post-bronchoscopy pneumonia in the cases who failed to receive the scheduled treatment with prophylactic antibiotics
3. Prevalence of adverse effects of prophylactic antibiotic treatment
4. Risk factors of post-bronchoscopy pneumonia
5. Prevalence of post-bronchoscopy pneumonia in the cases treated with prophylactic antibiotics, excluding the cases examined with endobronchial ultrasonography-guide sheath method
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
NO
NO
Institution is not considered as adjustment factor.
NO
No need to know
1
Prevention
Medicine |
Sulbactam / Ampicillin 1.5g, intravenous drip infusion within 1 hour before bronchoscopy, then Augmentin Combination Tablets (Potassium Clavulanate, Amoxicillin Hydrate) 750 mg, Amoxicillin Hydrate 750mg, tid for 3 days. If eGFR is 10-49 mL/min, dose of Augmentin Combination Tablets and Amoxicillin Hydrate is reduced to 500 mg, bid.
20 | years-old | <= |
Not applicable |
Male and Female
1. Trans-bronchial tumor biopsy for the diagnosis of lung cancer is scheduled
2. High risk patient for post-bronchoscopy pneumonia; two or more factors among "age 70 years or older", "current smoker", "presence of central lesion on chest CT scan" are positive
3. Written informed consent has been obtained
1. Presence of active infection at bronchoscopy
2. Body temperature 37 degree Celcius or higher at bronchoscopy
3. History of antibiotic therapy within 2 weeks prior to bronchoscopy
4. History of drug allergy to beta-lactam antibiotics
5. Presence of severe renal dysfunction with eGFR less than 10 mL/min
6. Other reasons which researchers consider inadequate to include in the study
120
1st name | Koichiro |
Middle name | |
Last name | Asano |
Tokai University School of Medicine
Division of Pulmonary Medicine, Department of Medicine
2591193
143 Shimokasuya, Isehara, Kanagawa, Japan
+81463931121
ko-asano@tokai-u.jp
1st name | Naoki |
Middle name | |
Last name | Hayama |
Tokai University School of Medicine
Division of Pulmonary Medicine, Department of Medicine
2591193
143 Shimokasuya, Isehara, Kanagawa, Japan
+81463931121
hayama@is.icc.u-tokai.ac.jp
Tokai University School of Medicine
Tokai University School of Medicine
Other
Japan
Institutional Review Board for Clinical Research, Tokai University
143 Shimokasuya, Isehara, Kanagawa, Japan
+81463931121
tokai-rinsho@ml.tokai-u.jp
NO
東海大学医学部付属病院(神奈川県)
2018 | Year | 04 | Month | 17 | Day |
Unpublished
Completed
2018 | Year | 01 | Month | 04 | Day |
2017 | Year | 12 | Month | 15 | Day |
2018 | Year | 04 | Month | 17 | Day |
2020 | Year | 04 | Month | 30 | Day |
2018 | Year | 04 | Month | 10 | Day |
2020 | Year | 10 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036686